Logo

Ena Cratsenburg, Will Schroeder

Jun 30, 2017

Ginkgo Bioworks has appointed Ena Cratsenburg as chief business officer and Will Schroeder as head of metabolic engineering. Cratsenburg joins Ginkgo with over a decade of experience in business development in the biotech space. She has held positions as senior VP of the consumer sector at Intrexon, senior VP of business development at Evolva, and VP of business development for Amyris. Schroeder joins Ginkgo from Archer Daniels Midland (ADM) where he served as CP of technology. Before ADM, Schroeder spent 12 years at Cargill, overseeing strain and fermentations process development.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.